Healthcare giants Boston Scientific, Johnson & Johnson and Medtronic were all reportedly interested in acquiring Shockwave Medical in 2023. Now, new rumors suggest a deal could be finalized within weeks. 

Average lengths of stay and common complications are just some of the factors care teams should consider when evaluating the costs of aortic valve replacement. 

Cardior Pharmaceuticals in Germany has been developing a new compound it says can “halt and partially reverse cellular pathology” in heart failure patients. 

While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the business side of things. 

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.

New research explored the potential savings of turning off angiography systems at night and on weekends.

Internal medicine physicians spend a lot of time working with heart failure patients. A new commentary in JACC: Heart Failure explored the potential impact of providing IM trainees with special training so that they can deliver additional value.

Aprocitentan, sold under the brand name Tryvio, is approved for patients with high blood pressure who are already taking other antihypertensive drugs.